Skip to content

A Study to Check the Safety and Effects of a Skin Patch (TDW) for Reducing Cravings and Increasing Fullness in Obese Adults.

An Open-Label Pilot Study to Evaluate the Effects and Safety of the Satiety-Enhancing Topical Formulation TDW on Cravings and Satiety in Obese Adults. - TOP-SAT

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/092536
Enrollment
15
Registered
2025-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z683- Body mass index (BMI) 30-39, adult

Interventions

None listed

Sponsors

Urrth Naturals LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: To participate in the study subjects must meet the following criteria 1 Age Male and female participants aged 25 to 60 years 2 Body Mass Index (BMI) BMI between 30.0 to 34.9 kilograms per square meter (Class I obesity) 3 Physical Activity Engaging in at least 30 minutes of moderate physical activity per day on most days of the week five or more days per week, and willing to maintain this activity level throughout the study period 4 Subjective Satiety Dysfunction Participants who score less than or equal to 19 on the Satiety Subscale of the New Zealand Eating Behaviour Questionnaire (NZ-EBQ) indicating moderate to poor satiety regulation 5 High Food Cravings Participants who score greater than or equal to 70 millimeters on VAS for Desire to Eat or Hunger OR self-report persistent cravings for unhealthy snacks despite regular meals 6.Subjective Hunger Index Baseline VAS score for Hunger greater than or equal to 60 millimeters out of 100 mm indicating elevated appetite levels. 7 Motivated for Diet Control Participants who selfreport difficulty adhering to a diet despite efforts at weight loss or dietary regulation 8 Consent and Compliance Willing and able to provide written informed consent and comply with all study procedures including daily application of the patch and completion of appetite mood questionnaires

Exclusion criteria

Exclusion criteria: A subject will be considered unsuitable for the study if they meet any one of the following criteria: 1 Use of appetite suppressants or weight loss medications 2 Presence of metabolic disorders eg diabetes thyroid disease 3 Significant skin conditions or known allergies especially those that may interfere with topical applications 4 Recent participation in any weight loss programs or clinical trials 5 Pregnancy or lactation 6 Current smokers 7 Heavy alcohol consumption

Design outcomes

Primary

MeasureTime frame
1 Improvement in satiety (measured by New Zealand Eating Behavior Questionnaire (NZ EBQ) 2 Reduction in cravings for snacking: 1 measured by Snacking Craving Scale Validated 3 Item VAS 2 measured by Visual Analogue Scale VAS Appetite AssessmentTimepoint: Visit-1 Screening (Day 0) Baseline Visit-2 (Day 15) + 2 days Visit-3 and EOS (Day 45) + 2 days

Secondary

MeasureTime frame
1 Change in mood measured by Profile of Mood States POMS 2 Change in perceived stress measured by Perceived Stress Scale PSS 3 Adverse events and serious adverse events throughout the study 4 Local skin tolerabilityTimepoint: Visit1 Screening Day 0 Baseline Visit2 Day 15 plus 2 days Visit-3 and EOS Day 45 plus days

Countries

India

Contacts

Public ContactShaitan Singh

VERISEARCH LAB PRIVATE LIMITED

cro.verisearchlab@gmail.com8826628182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026